DRG Epidemiology’s coverage of neuroendocrine tumor comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
DRG Epidemiology’s coverage of neuroendocrine tumor comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
Clarivate Epidemiology’s coverage of hospital treated (HT) gram-positive infections (GPIs) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the…
DRG Epidemiology’s coverage of diabetic macular edema (DME) comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceutical markets worldwide. We report…
Clarivate Epidemiology’s coverage of thyroid cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed…
The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a…
Based on DRG’s gold-standard Epidemiology data, the Interactive Patient Flow Model provides insight into the epidemiology of HCV for five different treatment scenarios.With the introduction of…
DRG Epidemiology’s coverage of pancreatic cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…
Methicillin-Resistant Staphylococcus aureus Epidemiology AbstractDRG Epidemiology’s coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient…
Methicillin-Resistant Staphylococcus aureus EpidemiologyDRG Epidemiology’s coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient populations…
Methicillin-Resistant Staphylococcus aureus EpidemiologyDRG Epidemiology’s coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient populations…
Methicillin-Resistant Staphylococcus aureus Epidemiology AbstractDRG Epidemiology’s coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient…
Clarivate Epidemiology’s coverage of hospital treated (HT) gram-positive infections (GPIs) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the…
Clarivate Epidemiology’s coverage of hospital treated (HT) gram-positive infections (GPIs) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the…
Clarivate Epidemiology’s coverage of hospital treated (HT) gram-positive infections (GPIs) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the…